Member Info for KilkennyTed

Another link for you. Simon Calder no less.
His last line does sum up our general handling of this situation. IMO

https://www.independent.co.uk/travel/news-and-advice/quarantine-heathrow-airport-flying-passengers-test-travel-coronavirus-a9602721.html

https://www.collinsongroup.com/en-eur/test-on-arrival

Snippet: Specifies it is a swab test.
Under the proposals travellers taking the RT-PCR swab test would continue to their quarantine address provided at the time of booking to await the result, which, if negative, would allow them to come out of self-isolation.

Evening all. Good to see some positivity on the board the past week. All looking good going forward. One sign is the trolls, derampers or whatever's have slipped back into the shadows. I don't have a problem with people venting their displeasure when companies don't perform as they think they should, but when certain people post negative comments time & again the filter button is pressed. I was just remembering a Thursday night about 3 weeks ago when nearly every other post was a green . I think this is when paulusoff was at his most prevalent. Well done to all those who stood their ground. VanV especially. We will have the last laugh when the supernova goes stratospheric & cash is coming in by the truckle load (cheese pun). Cheers all.

Can almost feel the tension. Looks like the lowest volume since 30th Jan.

The last statement is interesting.
"In other words, the lions’ share of price gains for the sector are probably behind us and further gains will be driven by companies which can translate orders into profits."
Which we know Novacyt is doing whilst some of the others are still in development.

I think the 3m net profit for 2020 would be a projected figure from way before the present situation raised it's head. We all know that the actual figure for net profit in 2020 will be much much higher.

Well said raharh. Nothing has changed fundamently. The SP was always going to dip due to new shares coming onto the market. Now's your chance to add to the pot at a very good price if you truly believe in the companies potential. Good luck.

It's been a hard couple of month's watching this slide. Let's hope this is the bounce we have all been waiting for. Good luck all. Hold on to your tickets as the Novacyt Express is about to leave the station.

C'mon Novacyt.

Cheers gg. Was a good game . Especially the last 15 mins.

Wow. It's like pedalling uphill in the Pyrenees.

Good evening all.
Just want to repost some details from the companies trading update of 9th June which informs us of a massive change in the companies operations to maximise potential. Why would any company change direction unless they had been guaranteed (imo) a greater return. You decide.

Trading update
Further to the announcement on 2 April 2020, the Company now expects EBITDA for the year ended 31 March 2020 to be in a range of £850k to £900k, which is slightly ahead of market expectations. This figure excludes the exceptional impairment charges referred to below.

Allergy
After additional review and evaluation of the use of development resources to deliver the highest potential financial returns, the Board has made the decision to stop on-going development of the allergy product range. Omega will continue to manufacture the 69 CE-Marked allergens developed to date, to meet the ongoing commercial demand from the Company's partner, Immunodiagnostic Systems ("IDS"). The decision to stop development was taken after a careful and thorough analysis of the best use of the Company's capital, people and assets, in the context of changes in underlying assumptions for the allergy business and has resulted in a decision to focus development activities in other areas.
Due to the changes in underlying assumptions, the Board has concluded that, in accordance with IAS36, it is prudent to impair fully the carrying value of intangible assets for the allergy business. Accordingly, an impairment charge of £8.73 million will be recognised in the financial year ended 31 March 2020, comprised of capitalised development costs of £7.25 million and a licence fee paid to IDS of £1.48 million. The impairment charge of £8.73 million will be offset by a credit to the profit and loss account of £1.02 million, being a proportionate amount of deferred income, previously recognised on the balance sheet relating to the Scottish Enterprise grant.

Good. I hope they all get burnt by the Fiery Tail of the SuperNova

Sorry if already posted.
https://www.labmate-online.com/news/laboratory-products/3/bbi-solutions/covid-19-uk-rapid-test-consortium-announces-significant-progress/52425

Peter2309
100% Agree. Being part of a Government backed consortium the news flow is going to be limited. Especially at this time when the government are under greater scrutiny. I think news will only come when it is 100%. Frustrating as it is when you see other companies releasing uplifting rns 2 or 3 times a month. Patience will pay off.

Thanks CCK.
That article has no connection to NCYT whatsoever.

Gap filled? Let's crack on.

Chrishar .
Conviction is key here. Do you/ we believe in our investment. I'm sure some who invested at the peak are doubting their decision or may even have sold at a loss. The past month has been brutal on the SP but you have to have conviction in your investments. What's has changed?
Increase in sales.
Cash in bank.
Debt free.
As GM has said this is a transformational time for the company. Many people talk about x amount per share when we get bought out. How about we set our sights on Aquisitions.
Is that too Rampy?

Can't believe Paulusoff is still getting airtime. Just filter the eejit.